Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MME | P08473 | 6/20 | 0.51 |
| ▸ | ACE | P12821 | 3/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.50 |
| ▸ | ABAT | P80404 | 1/20 | 0.49 |
| ▸ | GAA | P10253 | 3/20 | 0.47 |
| ▸ | MAPT | P10636 | 2/20 | 0.47 |
| ▸ | LMNA | P02545 | 2/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.47 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.47 |
| ▸ | HPGD | P15428 | 1/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | ECE1 | P42892 | 1/20 | 0.46 |
| ▸ | BLM | P54132 | 1/20 | 0.46 |
| ▸ | NPEPPS | P55786 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.45 |
| ▸ | ITGB1 | P05556 | 1/20 | 0.45 |
| ▸ | ITGAV | P06756 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28139032 | 0.84 | CTSL (0.48) | MMEALDH1A1 | |
| SCHEMBL11675813 | 0.84 | ALDH1A1 (0.51) | MMEACEALDH1A1GAAMAPT | |
| SCHEMBL11100514 | 0.84 | ALDH1A1 (0.46) | ALDH1A1GAALMNATDP1HPGD | |
| SCHEMBL30415753 | 0.83 | MME (0.49) | MMEACEALDH1A1ABATGAA | |
| SCHEMBL27570109 | 0.83 | ACE (0.49) | MMEACEALDH1A1GAAECE1 | |
| SCHEMBL28110897 | 0.83 | MME (0.49) | MMEACEALDH1A1ABATGAA | |
| SCHEMBL11340286 | 0.81 | CTSS (0.50) | ALDH1A1GAA | |
| SCHEMBL28237975 | 0.81 | ALDH1A1 (0.42) | MMEACEALDH1A1GAAMAPT | |
| Bromide SCHEMBL10907178 | 0.81 | PPID (0.51) | ALDH1A1GAAMAPTLMNAHPGD | |
| SCHEMBL8012043 | 0.80 | TDP1 (0.52) | ALDH1A1GAAMAPTLMNATDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-106537145-A | Small molecule biochemical profiling of individual subjects for disease diagnosis and health assessment | 麦特博隆股份有限公司 | 2017-03-22 | — | — | CN | claimed |
| CN-102300870-B | Low molecular weight polysulfated hyaluronic acid derivatives and medicines containing the same | OTSUKA CHEMICAL CO LTD | 2014-12-03 | — | — | CN | claimed |
| CN-1119340-C | Carbamoyloxy compounds that inhibit VLA-4 mediated leukocyte adhesion | ELAND PHARMACEUTICALS CO (US) | 2003-08-27 | — | — | CN | claimed |
| US-20030092608-A1 | Pharmaceutical composition for inhibiting the metastasis or preventing the recurrence of malignant tumor | TANABE SEIYAKU CO., LTD. (JP) | 2003-05-15 | — | — | US | claimed |
| CN-1265657-A | Carbamoyloxy compounds that inhibit VLA-4 mediated leukocyte adhesion | ELAND PHARMACEUTICALS CO (US) | 2000-09-06 | — | — | CN | claimed |
| US-5892043-A | MIXTURE WITH POLYSACCHARIDE AND PEPTIDE; ANTITUMOR AGENT | TANABE SEIYAKU CO., LTD. (JP) | 1999-04-06 | — | — | US | claimed |
| EP-0757049-B1 | Camptothecin derivatives | TANABE SEIYAKU CO (JP) | 1999-03-24 | — | — | EP | claimed |
| CN-1060408-A | Improved vaccine combination | NORTH AMERICAN VACCINE INC (CA) | 1992-04-22 | — | — | CN | claimed |
| CN-1056816-A | The vaccine combination of improvement | NORTH AMERICAN VACCINES INC (CA) | 1991-12-11 | — | — | CN | claimed |
| CN-109153635-A | Neuropeptide S receptor (NPSR) agonist | 研究三角协会 | 2019-01-04 | — | — | CN | disclosed |
| CN-106537145-A | Small molecule biochemical profiling of individual subjects for disease diagnosis and health assessment | 麦特博隆股份有限公司 | 2017-03-22 | — | — | CN | disclosed |
| CN-102300870-B | Low molecular weight polysulfated hyaluronic acid derivatives and medicines containing the same | OTSUKA CHEMICAL CO LTD | 2014-12-03 | — | — | CN | disclosed |
| CN-1942161-B | Compositions and treatments for demyelinating diseases and paralysis by administration of remyelinating drugs | ELAN PHARM INC | 2012-05-30 | — | — | CN | disclosed |
| CN-102300870-A | Low molecular weight polysulfated hyaluronic acid derivatives and medicines containing the same | — | 2011-12-28 | — | — | CN | disclosed |
| US-20060052288-A1 | Pharmaceutical composition for inhibiting the metastasis or preventing the recurrence of malignant tumor | MITSUBISHI TANABE PHARMA CORPORATION (JP) | 2006-03-09 | — | — | US | disclosed |
| CN-1119340-C | Carbamoyloxy compounds that inhibit VLA-4 mediated leukocyte adhesion | ELAND PHARMACEUTICALS CO (US) | 2003-08-27 | — | — | CN | disclosed |
| US-20030092608-A1 | Pharmaceutical composition for inhibiting the metastasis or preventing the recurrence of malignant tumor | TANABE SEIYAKU CO., LTD. (JP) | 2003-05-15 | — | — | US | disclosed |
| CN-1265657-A | Carbamoyloxy compounds that inhibit VLA-4 mediated leukocyte adhesion | ELAND PHARMACEUTICALS CO (US) | 2000-09-06 | — | — | CN | disclosed |
| CN-1129217-A | Baccatin derivatives and processes for the preparing the same | TANABE SEIYAKU CO (JP) | 1996-08-21 | — | — | CN | disclosed |
| CN-1060408-A | Improved vaccine combination | NORTH AMERICAN VACCINE INC (CA) | 1992-04-22 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030092608-A1 | Pharmaceutical composition for inhibiting the metastasis or preventing the recurrence of malignant tumor | CD44, MUC1, HGFAC | MME 52/4885ACE 753/4885ALDH1A1 4169/4885 |
| US-20060052288-A1 | Pharmaceutical composition for inhibiting the metastasis or preventing the recurrence of malignant tumor | CD44, MUC1, HGFAC | MME 52/4885ACE 753/4885ALDH1A1 4169/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.